SCHEMBL25459657

SCHEMBL25459657

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc4nc(-c5cccc(-n6c7ccccc7c7cc8c9ccccc9n(-c9ccccc9)c8cc76)c5)oc4c3)n2)cc1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 5/20 0.40
▸ SMN1; SMN2 Q16637 5/20 0.40
▸ ALDH1A1 P00352 4/20 0.40
▸ KMT2A Q03164 4/20 0.40
▸ HPGD P15428 3/20 0.40
▸ TP53 P04637 3/20 0.40
▸ MEN1 O00255 3/20 0.40
▸ HSD17B10 Q99714 2/20 0.40
▸ PKM P14618 1/20 0.40
▸ VSIR Q9H7M9 3/20 0.39
▸ HPSE Q9Y251 3/20 0.39
▸ MAPT P10636 4/20 0.38
▸ NPC1 O15118 3/20 0.38
▸ RAB9A P51151 3/20 0.38
▸ GPR119 Q8TDV5 4/20 0.38
▸ L3MBTL1 Q9Y468 2/20 0.37
▸ ATM Q13315 1/20 0.37
▸ GLA P06280 1/20 0.36
▸ GAA P10253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25459628 0.95 SMN1; SMN2 (0.44) KDM4ESMN1; SMN2ALDH1A1KMT2AHPGD
SCHEMBL25459674 0.94 VSIR (0.41) KDM4ESMN1; SMN2ALDH1A1KMT2AHPGD
SCHEMBL25459656 0.94 GPR119 (0.41) KDM4ESMN1; SMN2ALDH1A1KMT2AHPGD
SCHEMBL25459871 0.93 GPR119 (0.43) KDM4ESMN1; SMN2ALDH1A1KMT2AHPGD
SCHEMBL25459665 0.92 SMN1; SMN2 (0.40) KDM4ESMN1; SMN2ALDH1A1KMT2AHPGD
SCHEMBL25459442 0.92 HPSE (0.45) KDM4ESMN1; SMN2ALDH1A1KMT2AHPGD
SCHEMBL25459683 0.91 KDM4E (0.47) KDM4ESMN1; SMN2ALDH1A1KMT2AHPGD
SCHEMBL25459679 0.91 VSIR (0.41) KDM4ESMN1; SMN2ALDH1A1KMT2AHPGD
SCHEMBL23079869 0.90 VSIR (0.42) KDM4ESMN1; SMN2ALDH1A1KMT2AHPGD
SCHEMBL25459873 0.89 GPR119 (0.42) KDM4ESMN1; SMN2ALDH1A1KMT2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230217814-A1 ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME LG DISPLAY CO., LTD. (KR) 2023-07-06 — — US disclosed
US-20230217814-A1 ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME LG DISPLAY CO., LTD. (KR) 2023-07-06 — — US disclosed
US-20230145469-A1 ORGANIC LIGHT EMITTING ELEMENT LG DISPLAY CO., LTD. (KR) 2023-05-11 — — US disclosed
US-20230145469-A1 ORGANIC LIGHT EMITTING ELEMENT LG DISPLAY CO., LTD. (KR) 2023-05-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230217814-A1 ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME AOX1, XDH, PPOX KDM4E 2446/4885SMN1; SMN2 4240/4885ALDH1A1 225/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback